{"id":"W4379337628","doi":"10.1200/jco.2023.41.16_suppl.4569","title":"Final results from SAUL, a single-arm international real-world study of atezolizumab (atezo) in 1004 patients (pts) with pretreated locally advanced/metastatic urinary tract carcinoma (UTC).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"Roche","keywords":"Medicine; Atezolizumab; Discontinuation; Clinical endpoint; Internal medicine; Metastatic Urothelial Carcinoma; Adverse effect; Urology; Population; Oncology; Clinical trial; Surgery; Immunotherapy; Gastroenterology; Cancer; Urothelial carcinoma; Bladder cancer; Nivolumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005910803,0.00104163,0.001255545,0.0004873686,0.0004406373,0.00140409,0.000630108,0.0008959118,0.003399556],"category_scores_gemma":[0.003172904,0.0005174357,0.001771313,0.0007522108,0.0005234039,0.0006310972,0.0006813461,0.001313344,0.0009957881],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007017576,"about_ca_system_score_gemma":0.0008271341,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001012372,"about_ca_topic_score_gemma":0.00217679,"domain_scores_codex":[0.9983428,0.001094452,0.0001012385,0.0001567845,0.0001725751,0.000132154],"domain_scores_gemma":[0.9974033,0.0007945866,0.000750313,0.0002283131,0.0002363521,0.0005871402],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6917953,0.007613089,0.1599915,0.001446194,0.01101172,0.000690101,0.0004219973,0.005493055,0.01323402,0.0003352753,0.038411,0.06955681],"study_design_scores_gemma":[0.3461904,0.1477252,0.4551495,0.0002131909,0.01100247,0.001231491,0.0002197397,0.003309027,0.006347361,0.0005682836,0.02788331,0.0001599303],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9381483,0.00569511,0.002439032,0.000819604,0.0001221552,0.003076986,0.04156592,0.000247773,0.007885171],"genre_scores_gemma":[0.935374,0.00126766,0.002404868,0.001252913,0.0001480192,0.002304128,0.05356739,0.0000931283,0.003587851],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005910803,"threshold_uncertainty_score":0.03125966,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1421393444483367,"score_gpt":0.43814280452401,"score_spread":0.2960034600756733,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}